Multiple Sclerosis Diagnosis Incorrect for Many Patients
For patients like Christina Applegate, a reassessment shows the importance of checking your diagnosis if treatments fail.
Updated on Oct. 20, 2026 in Alzheimer’s

Actress Christina Applegate recently learned that her 2021 diagnosis of multiple sclerosis was incorrect after a follow-up medical evaluation. The case highlights the complexity of diagnosing neurological conditions, with experts estimating that as many as one in five people may be misdiagnosed with MS.
Why it matters
A correct diagnosis is critical for tailoring physical therapy and long-term care plans for patients with neurological symptoms. This update emphasizes that patients who do not experience the expected clinical improvement under a specific treatment plan should seek a secondary evaluation of their diagnosis.
Medical literature indicates that nearly one in five individuals diagnosed with multiple sclerosis may actually have a different condition. It remains unknown what specific alternative diagnosis or underlying condition accounts for the symptoms reported by the patient.
The players
Christina Applegate
An actress who has been navigating a complex neurological condition and currently utilizes a wheelchair for mobility.
The details
Doctors reassessed Applegate's case by reviewing her initial symptom reports, neurological examinations, and imaging results. A key component of the re-evaluation involved monitoring how her body responded after a previously prescribed infusion treatment was discontinued. This process underscores the necessity of ongoing clinical observation to ensure that treatment protocols align with the patient's true neurological status.
Timeline
2021: Christina Applegate initially announced her multiple sclerosis diagnosis.
October 2026: Applegate announced that the diagnosis was determined to be incorrect.
Health Landscape
Neurological conditions often present with overlapping symptoms, contributing to a known challenge in clinical medicine regarding diagnostic accuracy. This case reflects a broader trend of reassessment within the field, where clinicians increasingly focus on distinguishing MS from other neurological disorders.
If you are managing a chronic neurological condition but are not seeing the expected clinical improvements, it is worth discussing the possibility of a second opinion with a neurologist. Be prepared to review your full history of imaging and treatment responses with your physician.
The takeaway
Misdiagnoses in neurology are a known clinical hurdle, affecting up to 20% of those initially labeled with MS. If a treatment regimen is not providing relief, consult your primary care physician or a specialist to revisit your diagnostic assessment.
Further reading
For more on understanding complex neurological diagnoses, visit our section on Alzheimer’s.








